益丰药房(603939.SH)发布前三季度业绩，归母净利润12.25亿元，同比增长10.27%

Core Viewpoint - Yifeng Pharmacy (603939.SH) reported a slight increase in revenue and a notable rise in net profit for the first three quarters of 2025, indicating stable growth in its financial performance [1] Financial Performance - The company achieved a revenue of 17.286 billion yuan for the first three quarters, reflecting a year-on-year growth of 0.39% [1] - The net profit attributable to shareholders reached 1.225 billion yuan, marking a year-on-year increase of 10.27% [1] - The non-recurring net profit was reported at 1.188 billion yuan, which represents a year-on-year growth of 8.80% [1] - Basic earnings per share stood at 1.01 yuan [1]